SkinnyRx
SkinnyRx lists compounded semaglutide and tirzepatide in both weekly injectable and daily sublingual formats. Its four catalog figures are starting prices, not verified universal continuing rates, and its terms separate Lean Rx's administrative role from independent clinical care.
Programs offered by SkinnyRx
Some programs use membership charges, separate medication billing, or formats that do not belong in a ranked price table. We show their actual published price basis and treatment format instead of forcing a misleading comparison.
GLP-1 treatment
4 programsCompounded Injectable Semaglutide
Weekly subcutaneous injection
Compounded Semaglutide Tablets
Daily sublingual tablet
Compounded Injectable Tirzepatide
Weekly subcutaneous injection
Compounded Tirzepatide Tablets
Daily sublingual tablet
Who operates the service
Lean Rx, Inc.: Administrative operator of the SkinnyRx service; its terms state that Lean Rx is not a healthcare provider.
Independent affiliated medical practices: U.S.-licensed clinicians review intake and prescribe only when medically appropriate; assignment varies by jurisdiction.
Provider-selected partner pharmacy: Prescription fulfillment follows clinician approval; one fixed patient-specific pharmacy is not published on the checked pages.
Billing and operations
Published starting prices: The live catalog starts injectable semaglutide at $199, semaglutide tablets at $249, and both tirzepatide formats at $299 per month; no universal flat continuing rate was verified.
Future subscription cancellation: Future months can be cancelled before the next shipment is prepared; terms also advise cancelling at least five days before renewal processing.
Prescription and shipment boundary: A full refund is offered before prescription review is completed. Fulfillment, shipped products, bundles, partial periods, promotions, and the advertised 90-day guarantee have additional limits.
Prescription shipping: The FAQ says tracking is typically issued within two business days after prescription approval and advertises free overnight shipping.
Evidence conflicts and limits
Catalog figures are starting prices: The checked product pages use 'from' and 'as low as' language without one verified flat continuing rate, so the catalog labels them as starting figures and does not force them into the price ranking.
- The current terms exclude compounded offerings in Alabama, Louisiana, and Mississippi; confirm eligibility during intake.
- Compounded drugs are not FDA-approved drug products, and advertised financing or guarantee terms should be reviewed before purchase.
What SkinnyRx states
- US-licensed clinicians
- State-licensed pharmacy fulfilment
- Prices published before intake
- United States only
- Clinician review before prescribing
- Refund when a clinician does not approve
These come from the company’s own public pages. We record what it says and do not audit it.
Where it operates
GLP-1 weight loss: not available in Alabama, Louisiana and Mississippi.
Questions about SkinnyRx
- How much does SkinnyRx cost?
- The pages checked on August 27, 2026 advertise injectable semaglutide from $199 a month, semaglutide tablets from $249, and both injectable and tablet tirzepatide from $299. These are starting figures; confirm the dose, term, renewal charge, and total before ordering.
- Can you cancel SkinnyRx and get a refund?
- SkinnyRx says an order can receive a full refund before a licensed provider completes prescription review. Once fulfillment begins, the current order becomes nonrefundable. Future subscription months can be cancelled before the next shipment is prepared, while shipped products, bundles, partial periods, promotional discounts, and its advertised 90-day guarantee have additional conditions.
- Where is SkinnyRx available and does it take insurance?
- The current terms exclude compounded offerings in Alabama, Louisiana, and Mississippi. SkinnyRx is cash pay and says it does not accept insurance. It supports FSA or HSA payment, but reimbursement is not guaranteed. Confirm eligibility during intake because state and product coverage can change.
Primary and independent sources
Facts above are linked to the current public records checked on the dates shown. Advertiser statements describe what the provider publishes; they are not an audit or clinical endorsement.




